FDA Announces Draft Guidance on Donor Eligibility for Human Cells, Tissues, and Cellular Products
January 07, 2025
January 07, 2025
WASHINGTON, Jan. 7 (TNSFR) -- The Food and Drug Administration (FDA) has announced the availability of a new draft guidance aimed at helping healthcare establishments determine the eligibility of donors for human cells, tissues, and cellular and tissue-based products (HCT/Ps).
This updated document provides general recommendations and clarifies various aspects of donor screening, medical history interviews, and testing protocols to ensure the safety of these products. The draft gui . . .
This updated document provides general recommendations and clarifies various aspects of donor screening, medical history interviews, and testing protocols to ensure the safety of these products. The draft gui . . .